Document Detail


Cardiac remodeling in systemic hypertension.
MedLine Citation:
PMID:  14871054     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Experimental and clinical studies provide evidence that hypertension is causally related to adverse cardiac structural changes, such as LA enlargement, LV hypertrophy and myocardial fibrosis, and functional changes inclusive of LV systolic and diastolic dysfunction. These changes are induced by both hemodynamic and nonhemodynamic factors. There is accumulating evidence from several small and large clinical trials that various classes of antihypertensive therapy prevent and regress LVH and myocardial fibrosis. Prevention and reversal of LVH are associated with an improvement in cardiac function and with a decline in risk of adverse cardiovascular outcomes. Prevention of LVH should be a priority in subjects with hypertension. In patients with hypertensive heart disease, the components of therapy must comprise optimization of BP and regression of LVH. Future targets of therapy in hypertensive heart disease may include regression of myocardial fibrosis, normalization of LA size, and improvement in LV diastolic function.
Authors:
Satish Kenchaiah; Marc A Pfeffer
Related Documents :
18447954 - Relation between myocardial edema and myocardial mass during the acute and convalescent...
17483124 - Effects of enzyme replacement therapy on the cardiomyopathy of anderson-fabry disease: ...
487544 - Cross-sectional echocardiography. i. analysis of mathematic models for quantifying mass...
11999664 - Clinical significance of iodine-123-15-(p-iodophenyl)-3-r, s-methylpentadecanoic acid m...
1514494 - Influence of mitral valve morphology on mitral balloon commissurotomy: immediate and si...
23315664 - Targeting of endothelin receptors in the healthy and infarcted rat heart using the pet ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review    
Journal Detail:
Title:  The Medical clinics of North America     Volume:  88     ISSN:  0025-7125     ISO Abbreviation:  Med. Clin. North Am.     Publication Date:  2004 Jan 
Date Detail:
Created Date:  2004-02-11     Completed Date:  2004-02-24     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  2985236R     Medline TA:  Med Clin North Am     Country:  United States    
Other Details:
Languages:  eng     Pagination:  115-30     Citation Subset:  AIM; IM    
Affiliation:
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, MA 02115, USA. skenchaiah@rics.bwh.harvard.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antihypertensive Agents / therapeutic use
Cardiomegaly / etiology,  physiopathology
Fibrosis
Humans
Hypertension / complications,  pathology,  physiopathology*
Ventricular Remodeling / physiology*
Chemical
Reg. No./Substance:
0/Antihypertensive Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Coronary flow reserve measurements in hypertension.
Next Document:  Renal function in the patient with hypertension.